Skip to content

Treatment Of Sciatica by Hijamah(cupping) therapy

"A Randomized Controlled clinical Study To Evaluate The Efficacy Of Hijamah Bil Shart in Irq-un-Nasa (Sciatica)" - Sciatica

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/018946
Enrollment
60
Registered
2019-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

Interventions

Intervention1: Hijamah (Wet cupping/ cupping with scarification): Group A: Hijamah at buttock and thigh, 3 sessions at 15 days interval Group B: Hijamah at calf muscle and ankle, 3 sessions at 15 days

Sponsors

Jamia Hamdard
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Already diagnosed patients of sciatica presenting with all or some of the following signs and symptoms Unilateral leg pain greater than low back pain radiating towards leg/ foot/toes Positive straight-leg-raising sign Numbness and/ or tingling sensation in the same distribution Pain intensity score of 30 -60 mm on a 100-mm visual analog scale (VAS) Willingness to accept wet cupping intervention

Exclusion criteria

Exclusion criteria: Pregnant and lactating women. Patients of previous back surgery/ lumbar spine surgery. Patients of spinal tumors, gross/fixed developmental deformity, cauda equine or vertebral fracture Patients of bleeding disorders Patients of anaemia (Hb Patients taking any other conservative treatment for sciatica (NSAIDS, corticosteroids, physiotherapy, acupuncture etc.) Patients with malignancy or any liver, kidney or heart disease Patients of of inherited neuropathy or neuropathy attributable to other causes like hypothyroidism, vitamin B12 deficiency etc. Motor weakness/Muscle wasting Patients suffering from Psychiatric disorders HIV/AIDS, HCV and HBsAg positive patients History of stroke, severe hypertension and uncontrolled diabetes mellitus Unwilling to participate in the study

Design outcomes

Primary

MeasureTime frame
Relief in pain due to sciaticaTimepoint: 0 day, 42 day

Secondary

MeasureTime frame
Improvement in Disability and Quality of lifeTimepoint: 0 day, 42 day

Countries

India

Contacts

Public ContactProf Yasmeen Shamsi

Jamia Hamdard

drwasiakhtar@gmail.com9027570265

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026